Yahoo Malaysia Web Search

Search results

  1. Biogenes Technologies is a Malaysian-based company in the field of biotechnology, especially in molecular diagnostics and genomics. We develop and commercialise technologies from this field for applications ranging from human healthcare to animal health, agriculture and environmental.

  2. We work fearlessly and go beyond because we care deeply about making a difference and changing lives. If you are inspired by helping others, driven to discover transformative medicines, and want a career that can make a difference, we want to hear from you! Search open positions. Where science meets humanity.

  3. Your healthcare partner for biopharmaceutical services. In 1993, Biogenetech started sales, marketing and distribution of biopharmaceutical products and nuclear medicines. In the past 25 years, Biogenetech has been continuously introducing for more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public ...

  4. May 22, 2024 · Biogen Inc. agreed to acquire Human Immunology Biosciences Inc. for as much as $1.8 billion in a deal aimed at bolstering the biotechnology giant’s pipeline of immune disease treatments.

  5. The potential to transform the lives of patients drives us at Biogen. Alzheimer’s Disease and Dementia. Our world-class neurology research and development organization is pushing toward novel approaches for previously intractable neurodegenerative conditions such as Alzheimer’s disease.

  6. www.biogen.com › companyCompany | Biogen

    Biogen. Company. Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity ...

  7. Nov 3, 2021 · MIT and Biogen have announced that they will collaborate with the goal to accelerate the science and action on climate change to improve human health. This collaboration is supported by a three-year, $7 million commitment from the company and the Biogen Foundation.